Defining novel therapeutic strategies for relapsed ovarian cancer

    NAME Dr Elaine Sanij
    CANCER TYPE Ovarian
    INSTITUTION Peter MacCallum Cancer Centre
    STATE Victoria
    GRANT TYPE $100,000
    PROJECT TYPE Research

    Defining novel therapeutic strategies for relapsed ovarian cancer

    High-grade serous ovarian cancer accounts for 70% of ovarian cancer . Despite good initial responses to chemotherapy, recurrence is common and its five-year survival rate of 43% has not improved over the past three decades. This project has the potential to establish a new treatment paradigm for this disease of high therapeutic need.